Genesis Royal Infirmary Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.76 M
- Revenue Growth 72.05%
- Profit Growth 218.22%
- Ebitda 230.91%
- Net Worth 196.14%
- Total Assets 174.75%
About Genesis Royal Infirmary
Genesis Royal Infirmary Private Limited (GRIPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 April 2017 (Seven years and nine months 12 days old ). Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.76 M.
Saravanan Gopinath, Saravanan Gobinathan, and Chandrakala Magudapathi serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85310TZ2017PTC028868
-
Company No.
028868
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Apr 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Genesis Royal Infirmary?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saravanan Gopinath
|
Director | 12-Apr-2021 | Current |
|
Saravanan Gobinathan
|
Director | 27-Apr-2017 | Current |
|
Chandrakala Magudapathi
|
Director | 27-Apr-2017 | Current |
Financial Performance of Genesis Royal Infirmary.
Genesis Royal Infirmary Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 72.05% increase. The company also saw a substantial improvement in profitability, with a 218.22% increase in profit. The company's net worth Soared by an impressive increase of 196.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genesis Royal Infirmary?
In 2020, Genesis Royal Infirmary had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Gobinathan Agro Farms Private LimitedSaravanan Gobinathan and Chandrakala Magudapathi are mutual person
Charges (Loans)
₹1.76 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2021 | Others | ₹0.76 M | Open |
| 18 Aug 2020 | Others | ₹1.00 M | Open |
How Many Employees Work at Genesis Royal Infirmary?
Unlock and access historical data on people associated with Genesis Royal Infirmary, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genesis Royal Infirmary, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genesis Royal Infirmary's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.